Shareholders approve re-appointment of Managing Director for three years
Shareholders at the 45th AGM (25th September, 2026, via VC/OAVM) approved the re-appointment of Dr. Himanshu C. Patel (DIN: 00087114) as Managing Director for a period of three years, from 1st August, 2026 to 31st July, 2029.
By ScoutQuest · · 1 min read
- MD Re-appointment
- Dr. Himanshu C. Patel (DIN: 00087114) re-appointed as Managing Director
- Term Duration
- 3 years, from 1st August, 2026 to 31st July, 2029
- AGM Date
- 45th AGM held on 25th September, 2026
- Resolution Type
- Special Resolution approved by shareholders
- Debarment Status
- Not debarred from holding office by any SEBI or other authority order
What was approved
- Dr. Himanshu C. Patel (DIN: 00087114) re-appointed as Managing Director.
- Term: 3 years, from 1st August, 2026 to 31st July, 2029.
- Approved by Special Resolution of members at the 45th Annual General Meeting held on 25th September, 2026 through VC/OAVM.
Why
His earlier term as Managing Director was to expire on 31st July, 2026, and the re-appointment was made in view of the continued responsibilities he shoulders.
Profile and relationships
- He is B.E., M.S., Ph.D., with more than 7 decades of experience in the medical and pharmaceuticals field.
- Dr. Himanshu C. Patel, Ms. Anar H. Patel and Mr. Dinesh B. Patel are related to each other.
Other points
The company confirms he is not debarred from holding the office of Director by virtue of any SEBI order or any other authority. This follows the earlier intimation dated 29th July, 2026.
What it means
This is a continuity event rather than a change of leadership, with shareholder approval formalising the existing Managing Director's continuation for another three-year term.
Also from Denis Chem Lab
Board meeting on 4th November, 2026 to consider and approve unaudited results for September quarter
23 Oct 2026
Denis Chem Lab Ltd shareholder sells 2.05% stake
16 Oct 2026
Shareholders approve re-appointment of Managing Director for three years
25 Sep 2026
More numbers
- Re-appointment termthree years
- Experience in medical and pharmaceuticals fieldmore than 7 decades
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.